Stepan Reports 4% Sales Growth and $604.5M Q1 Revenue Despite 14% EBITDA Drop
Stepan delivered 4% organic sales growth and $604.5m Q1 revenue while adjusted EBITDA fell 14% and reported a $41.4m loss ($1.81/sh), reflecting production timing issues and elevated material costs. It took a $65.4m restructuring charge, plans $100m Catalyst savings, and will recover half of a $7m surfactant headwind next quarter.
1. Q1 Financial Performance
Stepan achieved 4% organic sales growth with $604.5m revenue, driven by double-digit volume increases in Crop Productivity, Oilfield and Industrial Cleaning. Adjusted EBITDA fell 14% due to production timing issues in Asia, lower absorption after a U.S. cold snap and sustained elevated material costs, resulting in a $41.4m loss ($1.81/sh).
2. Strategic Savings Initiatives
Project Catalyst targets $100m in pretax savings over two years, with 60% earmarked for 2026. The Pasadena, Texas facility is projected to reach 80% utilization this year, and management expects to recover half of a $7m surfactant EBITDA headwind next quarter while maintaining pricing amidst raw material inflation.
3. Restructuring and Asset Transactions
The company recorded a $65.4m pretax restructuring charge for the Hillsborough closure and Millsdale/Stalybridge decommissioning, and agreed to sell nonproductive Millsdale land for $30m in fall 2026. Ongoing geopolitical risks, notably in Iran, could continue to pressure raw material supply and costs.